January 11, 2011

While a majority of physicians are comfortable with generic medications, there is a small segment who still have negative perceptions about the effectiveness and quality of generic drugs, and that may lead to doctors prescribing unnecessarily expensive medications, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark.

December 17, 2010

Patent settlements between branded and generic drug companies, sometimes called “pay-for-delay” deals, aren’t going away any time soon.

December 14, 2010

Legislation to ban patent litigation settlements between branded and generic drug companies appears unlikely to find success, according to published reports.

November 15, 2010

Generic drug maker Actavis has filed for approval of a generic version of an antidepressant...

October 20, 2010

The Food and Drug Administration could decide that some generic drugs are not equivalent to...

September 26, 2010

Greenstone announced the launch of an authorized generic version of the Alzheimer’s disease drug Aricept...

September 9, 2010

The federal government got a kick in the face Thursday as an appeals court ruled...

August 11, 2010

The main lobbying group for the generic drug industry said federal authorities erred in projecting...

June 13, 2010

Indian generic drug maker Lupin is challenging a Gilead Sciences patent for a drug that...

May 25, 2010

Generic drug maker Watson Pharmaceuticals is challenging the patent on a drug for treating kidney...

March 17, 2010

A ban on patent settlements between branded and generic drug companies appears to have been...

March 15, 2010

Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...

February 22, 2010

President Barack Obama’s proposed healthcare bill may have its supporters and detractors, but one group...

January 13, 2010

Moody’s Investors Service announced Wednesday that it had upgraded the ratings of generic drug maker...

January 12, 2010

Teva hopes to garner revenues of $31 billion and net income of $6.8 billion by...